At Capsugel, we are devoted to developing capsules and other solutions to support our customers most difficult dosing challenges.
At Capsugel, we are driven by our focus on quality and have implemented numerous process quality initiatives to continuously improve the overall quality of our products.
At Capsugel, we are committed to ensuring an unmatched certainty of supply for our customers - and since you span the globe, so do we, with multiple production and business facilities worldwide.
World Class People
At Capsugel, we are focused on bringing and keeping top talent in our organization - it's our way of making sure you have the high-quality capsules you need, when and where you need them.
World Class People
At Capsugel, we are motivated by seeing our customers satisfied - so we keep your needs at the center of all our decisions to help make your job easier.
At Capsugel, we are dedicated to creating value for both our customers and their customers while always striving to provide investors with superior returns.
Multi-Disciplinary Approach to Optimize and Redefine Bioreactor Operations
April 16, 2014, 11:00 AM - 12:00 PM ET - The focus of the presentation will be on introducing an emerging process-development methodology that is based on applying novel and existing bioreactor monitoring technologies to existing bioreactor processes, coupled with applied mathematics and data-integration techniques across disciplines. This methodology offers an improved way to turn large raw data sets into useful guidance for process development and guidance. This methodology enables better use of existing data, as well as strategies to generate more frequent and higher-quality data sets to meet the dynamic nutrient requirements of cell cultures. This approach employs the use of dielectric spectroscopy (DS), other enhanced process-analytical technologies (PATs), and cell-based bioreactor models with a simple, compact device that automatically obtains samples aseptically at specified intervals for off-line analysis.
Bioavailability Enhancement Webinar Series - Formulation & Processing of Amorphous Solid Dispersions for Poorly Soluble Drugs by Hot-Melt
March 12, 2014, 11:00 AM - 12:00 PM ET - A large majority of active pharmaceutical ingredients (API) currently in development have limited bioavailability due to low solubility and dissolution rates (BCS IIa and IIb). The integrated Capsugel Dosage Form Solutions and Bend Research development team have a full range of established technologies and rigorous selection criteria to address this problem on a per API basis. In this webinar, hot-melt extrusion (HME) of amorphous solid dispersions is one approach used to address APIs with limited bioavailability due to low solubility and dissolution rates (BCS IIa / IIb).
Strategies for improving capsule filling efficiency
Finding the right balance of equipment, capsule, and formulation can boost yields, increase filling speed, and reduce downtime, allowing you to deliver products more quickly and increase profits. Read more about improving capsule filling efficiency in this article issued by Tablets and Capsules, January 2014.
Bend Research is now part of Capsugel's Dosage Form Solutions (DFS) business. Bend Research brings expertise in novel formulations, including spray-dried dispersions and hot-melt extrusion, as well as technologies in the areas of controlled-release, inhalation and bio-therapeutics. These capabilities complement Capsugel DFS’ premier capabilities in lipid and liquid formulations, modified and targeted release delivery and specialized manufacturing solutions.
Encap Drug Delivery
Based in Scotland, Encap’s focus on liquid and semi-solid encapsulation-based product development, and clinical and commercial manufacturing for the pharmaceutical industry, complements Capsugel’s recently-established Dosage Form Solutions (DFS) business unit which develops and manufactures innovative products for the healthcare industry.